American Healthcare REIT, Inc. current report, 30 December 2016

Business Context and Reporting Period

This Form 8-K is filed by Griffin-American Healthcare REIT IV, Inc. (the "Registrant") on December 30, 2016. The filing reports "Other Events" under Item 8.01 regarding the execution of executive stock purchase plans by key personnel of the Registrant and its co-sponsor, American Healthcare Investors, LLC.

Key Financial Metrics

The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial figure disclosed is the share purchase price of $9.21 per share for Class I common stock, which reflects the public offering price reduced by dealer manager fees funded by the Registrant.

Material Changes

There are no material changes to financial results or operations reported in this filing. The document details a new corporate action: the establishment of stock purchase plans for executives effective January 1, 2017.

Guidance, Outlook, and Management Commentary

  • Executive Stock Purchase Plans: Jeffrey T. Hanson (Chairman/CEO), Danny Prosky (President/COO), and Mathieu B. Streiff (EVP/General Counsel) agreed to invest 100% of their net after-tax base salary and cash bonus earned on or after January 1, 2017, into Class I common stock.
  • Additional Stock Purchase Plans: Three Executive Vice Presidents, including Stefan K.L. Oh, agreed to invest between 5% and 15% of their net after-tax base salary or bonus into Class I common stock.
  • Terms: Purchases commence with the payroll on January 23, 2017, and terminate on December 31, 2017, or earlier upon the termination of the public offering.
  • Fees: No selling commissions, dealer manager fees, or stockholder servicing fees will be paid on these specific transactions.

Investor Verification Checklist

  • Verify the total number of shares purchased by executives under these plans in subsequent filings.
  • Confirm the status of the public offering of securities, as the plans terminate if the offering ends early.
  • Review the Registrant's prospectus to understand the full structure of the $9.21 share price and the associated dealer manager fees.